184 related articles for article (PubMed ID: 7619017)
21. Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.
Seshadri S; Drachman DA; Lippa CF
Arch Neurol; 1995 Nov; 52(11):1074-9. PubMed ID: 7487559
[TBL] [Abstract][Full Text] [Related]
22. Influence of the apolipoprotein E type 4 allele on cerebral glucose metabolism in Alzheimer's disease patients.
Lee KU; Lee JS; Kim KW; Jhoo JH; Lee DY; Yoon JC; Lee JH; Lee DS; Lee MC; Woo JI
J Neuropsychiatry Clin Neurosci; 2003; 15(1):78-83. PubMed ID: 12556576
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease.
Hyman BT; Gomez-Isla T; Rebeck GW; Briggs M; Chung H; West HL; Greenberg S; Mui S; Nichols S; Wallace R; Growdon JH
Ann N Y Acad Sci; 1996 Dec; 802():1-5. PubMed ID: 8993478
[TBL] [Abstract][Full Text] [Related]
24. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease.
Galasko D; Saitoh T; Xia Y; Thal LJ; Katzman R; Hill LR; Hansen L
Neurology; 1994 Oct; 44(10):1950-1. PubMed ID: 7936253
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein E epsilon 4 allele and whole brain atrophy in late-onset Alzheimer's disease.
Yasuda M; Mori E; Kitagaki H; Yamashita H; Hirono N; Shimada K; Maeda K; Tanaka C
Am J Psychiatry; 1998 Jun; 155(6):779-84. PubMed ID: 9619150
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.
St Clair D; Norrman J; Perry R; Yates C; Wilcock G; Brookes A
Neurosci Lett; 1994 Jul; 176(1):45-6. PubMed ID: 7970234
[TBL] [Abstract][Full Text] [Related]
27. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease.
Gomez-Isla T; West HL; Rebeck GW; Harr SD; Growdon JH; Locascio JJ; Perls TT; Lipsitz LA; Hyman BT
Ann Neurol; 1996 Jan; 39(1):62-70. PubMed ID: 8572669
[TBL] [Abstract][Full Text] [Related]
28. Alzheimer's disease and the apolipoprotein E epsilon 4 allele.
Friedman G; Ben Yehuda A
Isr J Med Sci; 1994 Jul; 30(7):545-7. PubMed ID: 8050887
[No Abstract] [Full Text] [Related]
29. The apolipoprotein E epsilon 4 allele in Parkinson's disease with Alzheimer lesions.
Egensperger R; Bancher C; Kösel S; Jellinger K; Mehraein P; Graeber MB
Biochem Biophys Res Commun; 1996 Jul; 224(2):484-6. PubMed ID: 8702415
[TBL] [Abstract][Full Text] [Related]
30. Apolipoprotein E-epsilon 4 allele and familial risk in Alzheimer's disease.
Li G; Silverman JM; Altstiel LD; Haroutunian V; Perl DP; Purohit D; Birstein S; Lantz M; Mohs RC; Davis KL
Genet Epidemiol; 1996; 13(3):285-98. PubMed ID: 8797010
[TBL] [Abstract][Full Text] [Related]
31. Head injury and risk of Alzheimer's disease by apolipoprotein E genotype.
O'Meara ES; Kukull WA; Sheppard L; Bowen JD; McCormick WC; Teri L; Pfanschmidt M; Thompson JD; Schellenberg GD; Larson EB
Am J Epidemiol; 1997 Sep; 146(5):373-84. PubMed ID: 9290497
[TBL] [Abstract][Full Text] [Related]
32. [The apolipoprotein E-epsilon 4 allele is a risk factor for Alzheimer disease with early and late onset].
Kurz A; Lautenschlager N; Haupt M; Zimmer R; von Thülen B; Altland K; Lauter H; Müller U
Nervenarzt; 1994 Nov; 65(11):774-9. PubMed ID: 7816154
[TBL] [Abstract][Full Text] [Related]
33. Apolipoprotein-E genotyping in Alzheimer's disease and frontotemporal dementia.
Gustafson L; Abrahamson M; Grubb A; Nilsson K; Fex G
Dement Geriatr Cogn Disord; 1997; 8(4):240-3. PubMed ID: 9213069
[TBL] [Abstract][Full Text] [Related]
34. alpha 1-Antichymotrypsin as a risk modifier for late-onset Alzheimer's disease in Japanese apolipoprotein E epsilon 4 allele carriers.
Yoshiiwa A; Kamino K; Yamamoto H; Kobayashi T; Imagawa M; Nonomura Y; Yoneda H; Sakai T; Nishiwaki Y; Sato N; Rakugi H; Miki T; Ogihara T
Ann Neurol; 1997 Jul; 42(1):115-7. PubMed ID: 9225693
[TBL] [Abstract][Full Text] [Related]
35. Distribution of apolipoprotein E4 isoform in Alzheimer's disease in Poland.
Bratosiewicz-Zapart J; Kłoszewska I; Sobów T; Liberski PP
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):221-2. PubMed ID: 9597090
[TBL] [Abstract][Full Text] [Related]
36. Association of apolipoprotein E allele epsilon 4 with late-onset sporadic Alzheimer's disease.
Lucotte G; Visvikis S; Leininger-Müler B; David F; Berriche S; Réveilleau S; Couderc R; Babron MC; Aguillon D; Siest G
Am J Med Genet; 1994 Sep; 54(3):286-8. PubMed ID: 7810590
[TBL] [Abstract][Full Text] [Related]
37. [Apolipoprotein E genotypes in patients investigated for dementia].
Johannsen P; Jakobsen JK; Jørgensen AL
Ugeskr Laeger; 1997 Sep; 159(38):5658-61. PubMed ID: 9340872
[TBL] [Abstract][Full Text] [Related]
38. Interaction of the H63D mutation in the hemochromatosis gene with the apolipoprotein E epsilon 4 allele modulates age at onset of Alzheimer's disease.
Combarros O; García-Román M; Fontalba A; Fernández-Luna JL; Llorca J; Infante J; Berciano J
Dement Geriatr Cogn Disord; 2003; 15(3):151-4. PubMed ID: 12584430
[TBL] [Abstract][Full Text] [Related]
39. Protective effect of apoE epsilon 2 in Alzheimer's disease.
Benjamin R; Leake A; McArthur FK; Ince PG; Candy JM; Edwardson JA; Morris CM; Bjertness E
Lancet; 1994 Aug; 344(8920):473. PubMed ID: 7914580
[No Abstract] [Full Text] [Related]
40. Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.
Allen SJ; MacGowan SH; Tyler S; Wilcock GK; Robertson AG; Holden PH; Smith SK; Dawbarn D
Neurosci Lett; 1997 Dec; 239(1):33-6. PubMed ID: 9547165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
